Vaccinations (DPT 3) (% of children ages 12-23 months): Q4 in Kazakhstan
Kazakhstan: Vaccinations (DPT 3) (% of children ages 12-23 months): Q4 was 84.0% in 2015. ▲ Rising
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4 in Kazakhstan, 1995–2015
Source: Household Surveys (DHS, MICS).
Analysis
The most recent figure for vaccinations (dpt 3) (% of children ages 12-23 months): q4 in Kazakhstan is 84.0%, measured in 2015.
Compared with earlier readings it is down 14.5% over ten years.
Over the whole period, vaccinations (dpt 3) (% of children ages 12-23 months): q4 in Kazakhstan peaked at 98.2% in 2006 and was at its lowest, 47.5%, in 1995.
Kazakhstan ranks 22nd of 40 countries on this measure, in the middle of the range.
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4 in Kazakhstan, year by year
| Year | Value | Change |
|---|---|---|
| 1995 | 47.5% | — |
| 1999 | 87.9% | +85.1% |
| 2006 | 98.2% | +11.7% |
| 2011 | 94.4% | -3.9% |
| 2015 | 84.0% | -11.0% |
Kazakhstan compared with similar countries
- Kazakhstan's 84.0% is below the median for upper middle income countries, which is 89.0%, 94% of the median. (10 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 67.7% | 47.5% | 87.9% | 2 |
| 2000s | 98.2% | 98.2% | 98.2% | 1 |
| 2010s | 89.2% | 84.0% | 94.4% | 2 |
Countries ranked near Kazakhstan
- 19 India 88.0% compare
- 20 Philippines 87.8% compare
- 21 Bolivia, Plurinational State of 86.2% compare
- 23 Togo 83.1% compare
- 24 Sierra Leone 82.3% compare
- 25 Indonesia 81.9% compare
More health data for Kazakhstan
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3158 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 825.8 deaths per 1,000 people (2090)
- Number of infants who die before age 1 660 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0485 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is vaccinations (dpt 3) (% of children ages 12-23 months): q4 in Kazakhstan?
- Vaccinations (dpt 3) (% of children ages 12-23 months): q4 in Kazakhstan was 84.0% in 2015, according to Household Surveys (DHS, MICS).
- What is the highest vaccinations (dpt 3) (% of children ages 12-23 months): q4 recorded in Kazakhstan?
- The highest recorded value was 98.2% in 2006.
- What is the lowest vaccinations (dpt 3) (% of children ages 12-23 months): q4 recorded in Kazakhstan?
- The lowest recorded value was 47.5% in 1995.
- How does Kazakhstan rank for vaccinations (dpt 3) (% of children ages 12-23 months): q4?
- Kazakhstan ranks 22nd out of 40 countries with data for 2015.
- Is vaccinations (dpt 3) (% of children ages 12-23 months): q4 rising or falling in Kazakhstan?
- Over the last ten years it is down 14.5%. The long-run trend across the full record is rising.
- Where does this Kazakhstan data come from?
- The figures come from Household Surveys (DHS, MICS), published as part of Vaccinations (DPT 3) (% of children ages 12-23 months): Q4. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Vaccinations: Percentage of children 12-23 months who have received specific vaccines by the time of the survey (according to the vaccination card or the mother's report). Children with all vaccinations refer children who have received BCG, measles, and three doses each of DPT and polio vaccine (excluding polio 0). Some MICS surveys refer children in different age groups (e.g. 18-29 months, or 15-26 months).